Company Overview of Prism Pharmaceuticals, Inc.
As of May 12, 2011, Prism Pharmaceuticals, Inc. operates was acquired by Baxter International Inc. Prism Pharmaceuticals, Inc., an acute care pharmaceutical company, engages in the development and commercialization of cardiovascular injectable products in the United States. Its products include NEXTERONE, an anti arrhythmic agent in the form of injectable amiodarone; and PM103, an intravenous formulation of clopidogrel bisulfate. The company was incorporated in 2003 and is based in King of Prussia, Pennsylvania.
1016 West Ninth Avenue
King of Prussia, PA 19406
Founded in 2003
Key Executives for Prism Pharmaceuticals, Inc.
Prism Pharmaceuticals, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Takeda Pharmaceuticals U.S.A., Inc.||United States|
|Escoublac Inc.||United States|
|ARK Diagnostics, Inc.||United States|
|Astrazeneca Neuroscience Innovative Medicines||United States|
|InnoPharma, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Prism Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.